C. Martins (G. Evan lab)explored the importance of loss of p53 function for leukemia maintenance using tamoxifen (TAM)-inducible p53 (p53ERTAM) [5] in spontaneous leukemias arising in Eμ-Myc transgenic mice in a p53ER/+ background. This evidence concerns the gene MYC and leukemia.